Contribution of intraoperative radiotherapy (IORT) for therapeutic de‐escalation in early breast cancer: Report of a single institution's experience

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The Breast Journal

• Publication date

  2018-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/tbj.12993PMID 29356235
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quality of life (QOL) and symptom burden (SB) in patients with breast cancer

  2017cited by this paper
• Intraoperative Radiotherapy for Breast Cancer

  2017cited by this paper
• Cosmesis and Breast-Related Quality of Life Outcomes After Intraoperative Radiation Therapy for Early Breast Cancer: A Substudy of the TARGIT-A Trial.

  2016influential reference
• Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT

  2016cited by this paper
• Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival

  2016cited by this paper
• Trends in Local Therapy Utilization and Cost for Early-Stage Breast Cancer in Older Women: Implications for Payment and Policy Reform.

  2016cited by this paper
• Long-Term Breast Cancer Patient Outcomes After Adjuvant Radiotherapy Using Intensity-Modulated Radiotherapy or Conventional Tangential Radiotherapy

  2016cited by this paper
• Reduced Mortality With Partial-Breast Irradiation for Early Breast Cancer: A Meta-Analysis of Randomized Trials.

  2016cited by this paper
• Omission of Breast Radiotherapy in Low-risk Luminal A Breast Cancer: Impact on Health Care Costs.

  2016cited by this paper
• An international randomised controlled trial to compare TARGeted Intraoperative radioTherapy (TARGIT) with conventional postoperative radiotherapy after breast-conserving surgery for women with early-stage breast cancer (the TARGIT-A trial).

  2016cited by this paper
• Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

  2015cited by this paper
• Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms

  2015cited by this paper
• Oncoplastic Surgery: Pushing the Limits of Breast‐Conserving Surgery

  2015cited by this paper
• Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts

  2014cited by this paper
• Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer.

  2014cited by this paper
• Intraoperative radiotherapy for breast cancer.

  2014cited by this paper
• Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

  2014cited by this paper
• [Sentinel node invasion: is it necessary to perform axillary lymph node dissection? Randomized trial SERC].

  2014cited by this paper
• Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery

  2013cited by this paper
• Electrons for intraoperative radiotherapy in selected breast-cancer patients: late results of the Montpellier phase II trial

  2013cited by this paper
• Clinical aspects of intraoperative radiotherapy in early breast cancer: short-term complications after IORT in women treated with low energy x-rays

  2013cited by this paper
• Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A

  2013influential reference
• Risk of ischemic heart disease in women after radiotherapy for breast cancer.

  2013cited by this paper
• Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.

  2013cited by this paper
• Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase III trial TARGIT A

  2012cited by this paper
• Ipsilateral breast tumor relapse: local recurrence versus new primary tumor and the effect of whole-breast radiotherapy on the rate of new primaries.

  2011cited by this paper
• Ipsilateral breast recurrence after breast conserving surgery in patients with small (≤ 2cm) breast cancer treated with modern adjuvant therapies.

  2011cited by this paper
• Postoperative seroma formation after intraoperative radiotherapy using low-kilovoltage X-rays given during breast-conserving surgery.

  2010cited by this paper
• Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach.

  2010cited by this paper
• Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.

  2008cited by this paper
• The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial

  2008cited by this paper
• Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.

  2006cited by this paper
• Infrastructure of radiation oncology in France: a large survey of evolution of external beam radiotherapy practice.

  2005cited by this paper
• Pattern of local recurrence after conservative surgery and whole-breast irradiation.

  2005cited by this paper
• Quality of life in breast cancer patients aged over 70 years, participating in the EORTC 10850 randomised clinical trial.

  2003cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

  2002cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer.

  2001cited by this paper
• Early stage breast cancer: costs and quality of life one year after treatment by mastectomy or conservative surgery and radiation therapy.

  2000influential reference
• Quality of life of early-stage breast cancer patients treated with radical mastectomy or breast-conserving procedures: results of EORTC Trial 10801. The European Organization for Research and Treatment of Cancer (EORTC), Breast Cancer Co-operative Group (BCCG).

  1998cited by this paper
• Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.

  1982cited by this paper

• Physicians’ Opinion on Intraoperative Radiotherapy as a Therapeutic De-Escalation Option in Older Women with Early Breast Cancer

  2023cites this paper
• Lived experience and perceived advantages of therapeutic De-escalation: A qualitative study of older patients with breast cancer.

  2022cites this paper
• Intraoperative Radiotherapy for Breast Cancer in Elderly Women.

  2021cites this paper
• Why should radiological oncology do translational research?

  2019cites this paper
• Intraoperative Radiation Therapy (IORT)

  2018cites this paper
• The current status of intraoperative radiation therapy in breast cancer: Challenges and promises

  2018cites this paper